Healthcare | Wednesday 21 March, 2018 4:39 am

Ebsar Foundation seeks TVTC's help to give job training to the visually impaired

The Ebsar Foundation, a non-profit organization that supports the visually challenged, has asked the Technical and Vocational Training Corporation (TVTC) to conduct training programs to qualify the visually impaired members of society for the job market and issue them accredited...

More Details

Healthcare | Tuesday 20 March, 2018 6:45 am

Long-awaited specialist hospital opens in Hail

Emir of Hail Prince Abdulaziz Bin Saad formally opened King Salman Specialist Hospital in this northern city in the presence of Health Minister Tawfiq Al-Rabiah and other top officials. The hospital, with a capacity of 500 beds, will provide healthcare to some 700,000 residents of the city. The...

More Details

Healthcare | Monday 19 March, 2018 7:00 am

New Novomed Medical Centers Promise to Revolutionize the UAE’s Approach to Health Care

Last night saw the official launch of a new group of medical centers at a ceremony held at Armani Dubai, Burj Khalifa, with attendees including the Director-General of Dubai Health Authority, Humaid Al Qatami.   Novomed Group founder, Dr Mazen Sawaf, better known as Dr Max, says the...

More Details

Healthcare | Sunday 18 March, 2018 12:31 pm

Nahdi Pharmacies Mark the International Women's Day & Mother Day With a Campaign

In every March each year, there are specific days designated for women and celebrated in many countries around the globe, including the International Women's Day and the Mother's Day. Celebrating such a joyful occasion, Nahdi Pharmacies launched the campaign "You're the Most...

More Details

Healthcare | Wednesday 14 March, 2018 5:17 pm

Ministry of Health and GE delivering digital solutions to bring transformative change to Kingdom’s healthcare sector

The Saudi Arabian Ministry of Health and GE (NYSE: GE) have delivered the first phase of a landmark Memorandum of Understanding (MOU) focused on digital transformation in healthcare, signed in May 2017 in the presence of the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud. In...

More Details

Healthcare | Wednesday 14 March, 2018 12:17 pm

AbbVie named the best pharmaceutical company to work for in Saudi Arabia for the fourth year in a row

AbbVie, a global research and development-based biopharmaceutical company, announced today that it has been named the top pharmaceutical company to work for in Saudi Arabia by Great Place to Work® for the fourth year in a row. Moreover, AbbVie went up one place and ranked second place in 2017...

More Details

Healthcare | Monday 12 March, 2018 12:45 pm

UAE’s first ICU Symposium attracts over 150 of GCCs top healthcare professionals

The Cambridge ICU Rehab Symposium 2018, organized by Cambridge Medical and Rehabilitation Center, UAE’s leading rehabilitation and post-acute care provider, was held at The Intercontinental Hotel, Dubai Festival City. The symposium, which was attended by over 150 healthcare professionals from ...

More Details

Healthcare | Monday 12 March, 2018 12:05 pm

Pink Caravan Ride Fixed Clinics Extend Deadline until March 15

In a bid to continue its efforts to reach out to heighten people’s awareness about the dangers of breast cancer and the importance of early detection in mitigating risks, the Pink Caravan Ride’s eighth annual edition which concluded last week has announced that the fixed clinics in...

More Details

Healthcare | Monday 12 March, 2018 10:55 am

BinSina Pharmacy aggressive expansion plan on course as 15 new outlets set to launch in the UAE

United Arab Emirates’ first licensed pharmacy, BinSina, announced today plans to open 15 new outlets in the country as it seeks to cement its leadership position as a major player in the region offering a wide range of  pharma, skincare, beauty, lifestyle, supplements and vitamins...

More Details

Healthcare | Monday 12 March, 2018 9:58 am

Alirocumab reduced risk of major adverse cardiovascular events by 24% and was associated with a 29% lower risk of death overall

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the ODYSSEY OUTCOMES trial met its primary endpoint, showing Praluent® (alirocumab) significantly reduced the risk of major adverse cardiovascular events (MACE) in patients who had suffered a recent acute coronary syndrome (ACS)...

More Details